title: Effects of raloxifene on adipocytokines in Japanese osteoporotic postmenopausal women with and without type 2 diabetes.
authors.affiliation: Department of Molecular Genetics of Cardiovascular Disorders, Graduate School of Medical Science, Kanazawa University, Ishikawa, Japan. in1254@poh.osaka-med.ac.jp
authors.forename: Y
authors.initials: Y
authors.lastname: Murase
authors.forename: J
authors.initials: J
authors.lastname: Kobayashi
authors.forename: A
authors.initials: A
authors.lastname: Asano
authors.forename: N
authors.initials: N
authors.lastname: Yamaaki
authors.forename: K
authors.initials: K
authors.lastname: Yonezawa
authors.forename: H
authors.initials: H
authors.lastname: Muramoto
authors.forename: H
authors.initials: H
authors.lastname: Mabuchi
mesh_terms: D000273:Adipose Tissue / Q000378:metabolism*; D000368:Aged; D000369:Aged, 80 and over; D015415:Biomarkers / Q000097:blood; D050218:Body Fat Distribution / Q000379:methods; D050071:Bone Density Conservation Agents / Q000008:administration & dosage*; D016207:Cytokines / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications; D005260:Female; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000150:complications / Q000188:drug therapy; D007564:Japan; D015663:Osteoporosis, Postmenopausal / Q000097:blood* / Q000150:complications / Q000517:prevention & control; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage*
chemical_list: D015415:Biomarkers; D050071:Bone Density Conservation Agents; D016207:Cytokines; D020849:Raloxifene Hydrochloride